- Staat
- AL
- Alter
- 0,2
- Geschlecht
- F
- Eingang
- 17.12.2021
- Impfdatum
- 24.11.2021
- Beginn
- 27.11.2021
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Body temperature increased
Catheter culture
Culture urine
Dehydration
Diarrhoea
Diarrhoea haemorrhagic
Full blood count
Gastritis
Impaired gastric emptying
Infant irritability
Metabolic function test
Respiratory viral panel
Stool analysis
Ultrasound abdomen
Weight decreased
Symptomtext
blood & mucus diarrhea, temp 101.8 R, fussiness, dehydration, weight loss, gastritis, gastroparesis
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dehydration
- Hospital-Tage
- 6,0
- Labordaten
- abdominal ultrasound x 3, cbc, cmp, speech evaluation, cath urine with culture, iv fluids, stool specimens, respiratory panel, 11/29/21-12/17/21
- Aktuelle Erkrankungen
- GERD
- Vorgeschichte
- GERD
- Andere Medikamente
- omeprazole
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 20.10.2021
- Impfdatum
- 11.10.2021
- Beginn
- 11.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Decreased appetite
Dizziness
Feeling abnormal
Headache
Heart rate decreased
Hypotension
Lethargy
Nausea
Pallor
Pyrexia
Tremor
Visual impairment
Symptomtext
Within minutes of receiving vaccinations, child became dizzy, nauseous and pale. Said her vision was becoming dark. Sat child down and asked nurse to get a doctor and to take her blood pressure, pulse and blood sugar. Child was hypotensive with a low heart rate. Had child drink some juice. Within 10 minutes Childs color began to regain and child stated she was feeling better. Remained in doctors office for 2 hours until her blood pressure recovered to a more normal level. Less than 24hrs later child was complaining about being shaky and dizzy. Soon after she had a low grade fever (99-100 F), complained of a bad headache, no appetite, nauseous, lethargic which lasted 6 days. PCP is referring her to cardiologist for continued hypotension.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- None known
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 25.07.2022
- Impfdatum
- 20.07.2022
- Beginn
- 24.07.2022
- Tage bis Beginn
- 4,0
- Dosis
- 5
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Decreased appetite
Dizziness
Lethargy
Nausea
Pyrexia
Vomiting
Symptomtext
Very high fever (104.5), nausea, vomiting, lethargy, dizziness, loss of appetite
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None known
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 6,0
- Geschlecht
- M
- Eingang
- 07.03.2023
- Impfdatum
- 01.03.2023
- Beginn
- 01.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
reporting a patient was administered expired IPOL , with no reported adverse event; Initial information was received on 02-Mar-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves 6 years old male patient who was reporting a patient was administered expired IPOL, with no reported adverse event after receiving IPV (Vero) [IMOVAX]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 01-Mar-2023, the patient received a dose 2 of 0.5 ml of suspect IPV (Vero) (Suspension for injection) (lot U1A451M, Expiry date : 20-Feb-2023) (strength was unknown) via intramuscular route in the left deltoid for immunization. On 01-Mar-2023 the patient developed a non-serious event of reporting a patient was administered expired ipol , with no reported adverse event (expired product administered) (latency: same day) following the administration of IPV (Vero). No lab data reported. Action taken :not applicable. At time of reporting, the outcome was Unknown for the event reporting a patient was administered expired ipol , with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 8,0
- Geschlecht
- M
- Eingang
- 24.01.2023
- Impfdatum
- 06.01.2023
- Beginn
- 06.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Medication error
No adverse event
Poor quality product administered
Product storage error
Symptomtext
Patient received a dose of IPOL that was no longer viable due to a temperature excursion with no reported adverse event; Initial information received on 18-Jan-2023 regarding an unsolicited valid non-serious case received via other health professional. This case involves a 8-year-old male patient who received a dose of IPV (VERO) [IPOL] that was no longer viable due to a temperature excursion with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided. On 06-Jan-2023, the patient received a 0.5 ml Total dose of suspect IPV (VERO) Suspension for injection (lot: U1A451M) (strength, expiry date: unknown) via unknown route in unknown administration site for immunization. On 06-Jan-2023 the patient had a non-serious event of patient received a dose of ipol that was no longer viable due to a temperature excursion with no reported adverse event (poor quality product administered) (latency: same day) following the administration of IPV (VERO). Action taken with POLIOMYELITIS VACCINE (INACTIVATED) (IPOL) was not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 24.01.2023
- Impfdatum
- 03.01.2023
- Beginn
- 03.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Medication error
No adverse event
Poor quality product administered
Symptomtext
Patient received a dose of IPOL that was no longer viable due to a temperature excursion with on reported AE; Initial information received on 18-Jan-2023 regarding an unsolicited valid non-serious case from a consumer/non-hcp. This case involves a 16-year-old female patient who experienced patient received a dose of ipol that was no longer viable due to a temperature excursion with on reported adverse event (AE) while receiving vaccine IPV (VERO) [IMOVAX POLIO]. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. Concomitant medications included Hepatitis B Vaccine, Hepatitis A Vaccine, meningococcal vaccine measles vaccine, mumps vaccine, rubella vaccine (MMR), varicella zoster vaccine (Varicella Vaccine) and diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP) all for prophylactic vaccination (Immunisation). On 03-Jan-2023, the patient received suspect IPV (VERO) at a dose of 0.5 ml once (lot U1A451M, expiry date: 20-Feb-2023) via unknown route in the right deltoid for Immunization. On 03-Jan-2023 the patient received a dose of ipol that was no longer viable due to a temperature excursion with on reported ae (poor quality product administered) same day following the administration of IPV (VERO). Action taken: Not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 0,3
- Geschlecht
- F
- Eingang
- 29.12.2022
- Impfdatum
- 04.10.2022
- Beginn
- 04.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
received the vaccine post excursion with no reported adverse event; Initial information received on 22-Dec-2022 regarding an unsolicited valid non-serious case received from other health professional. This case is linked to case 2022SA518461. This case involves a 4 months old female patient who received the vaccine post excursion with no reported adverse event after receiving vaccine IPV (VERO) [IPOL]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DTAP); ROTAVIRUS VACCINE, PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) and HIB VACCINE (HIB) for Immunization. On 04-Oct-2022, the patient received a (series: 2nd dose) suspect IPV (VERO) (Batch/lot number -U1A451M)(Dose-0.5mL)(Frequency-Total/once )(Expiry date-20-FEB-2023)( Strength = standard)(Formulation- Suspension for injection) via intramuscular route in the right thigh for Immunization . On 04-OCT-2022 the patient developed a non-serious event received the vaccine post excursion with no reported adverse event (poor quality product administered) following the administration of IPV (VERO).(Latency- same day) It was reported The caller advised there were 3 patients that received the vaccine post excursion. Caller advised a couple months ago she called in reporting a temperature excursion at their facility where IPOL was concluded to no longer be viable. Action Taken : not applicable. At time of reporting, the outcome was Unknown for the event received the vaccine post excursion with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: case number 01312315:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 11.08.2022
- Impfdatum
- 29.07.2022
- Beginn
- 29.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
administered Ipol post excursion after it had exceeded extended stability data and was no suitable for use with no reported adverse event; Initial information received on 04-Aug-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 16 years old male patient who was administered IPV (VERO) [IPOL] post excursion after it had exceeded extended stability data and was no suitable for use with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included MENINGOCOCCAL VACCINE A/C/Y/W CONJ (DIP TOX) (MENACTRA) ; HEPATITIS B VACCINE (HEPATITIS B [HEPATITIS B VACCINE]) ; MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR) ; DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP) ; and VARICELLA ZOSTER VACCINE (VARICELLA VACCINE) all for prophylactic vaccination (Immunization). The reporter informed that the temperature excursion was caused by a air conditioner malfunction and the temperature reached 0.8 C for duration of 36 hours 38 minutes. The punctured Ipol was not covered under the extended stability data. On 29-Jul-2022, the patient received first dose of suspect IPV (VERO), with an unknown formulation and strength, at dose of 0.5 ml once, (lot: U1A451M ; expiry date: 20-Feb-2023) via intramuscular route in the right deltoid for immunization. It was reported that the patient was administered Ipol post excursion after it had exceeded extended stability data and was no suitable for use with no reported adverse event (poor quality product administered) (onset date: 29-Jul-2022) (latency: same day) following the administration of IPV (VERO). Action taken : not applicable. Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 19.03.2022
- Impfdatum
- 24.11.2021
- Beginn
- 19.03.2022
- Tage bis Beginn
- 115,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Provider administered Polio vaccine to 68 year old pt as pt reported to provider this was what she wanted, however, the patient had intended to get a Prolia injection instead...IPOL administered outside of recommended guidelines. Pt does not report any adverse side effects as a result of the vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 01.03.2022
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Symptomtext
Pt given MMRV (Proquad) and Varicella (Varivax) in same visit. No reaction after 15 min observation. Advised to monitor for anaphylaxis symptoms or seizures and go to nearest emergency hospital and notify the health department after discharge.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- no drug allergies, no allergies to any previous vaccines, no food allergies
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 9,0
- Geschlecht
- M
- Eingang
- 15.02.2022
- Impfdatum
- 10.02.2022
- Beginn
- 10.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Product administered to patient of inappropriate age
Symptomtext
Child inadvertently given Adult formulation of Engerix B- Hepatitis B vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 15.02.2022
- Impfdatum
- 10.02.2022
- Beginn
- 10.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
Child was inadvertently given Adult formulation of Engerix B (Hepatitis B) vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AK
- Alter
- 1,7
- Geschlecht
- F
- Eingang
- 15.12.2021
- Impfdatum
- 15.12.2021
- Beginn
- 15.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
No adverse effect reported yet. I had intended to administer varicella vaccine, but gave IPV instead. Polio was not due yet: recommended 4th dose 3/19/24, but minimum valid date is 4/6/21, so unlikely that this will significantly interfere with child's immunization schedule. We are working to obtain varicella vaccine as child is overdue (has not had any varicella vaccine). Challenge in this remote location is the short shelf life of the vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- s/p VSD and ASK, fetal exposure to alcohol
- Andere Medikamente
- acetaminophen
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 0,1
- Geschlecht
- M
- Eingang
- 14.12.2021
- Impfdatum
- 08.11.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
A four week old patient received Daptacel and not Adacel, Ipol, and ActHIB with no ae; Initial information received on 30-Nov-2021 regarding an unsolicited valid non-serious case received from a consumer non health care professional. This case involves a 34 days old male patient who was administered POLIOMYELITIS VACCINE (INACTIVATED) [IPOL] (product administered to patient of inappropriate age). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 5-COMPONENT, TETANUS VACCINE TOXOID (ADACEL), HIB VACCINE CONJ (TET TOX) (ACTHIB), DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DAPTACEL), ROTAVIRUS VACCINE (ROTAVIRUS VACCINE), and PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR). On 08-Nov-2021, the patient received a 0.5 ml dose of suspect IPV (VERO) lot number: U1A451M and expiry date not reported via intramuscular route in the left thigh for prophylactic vaccination. It was case of an actual medication error due to inappropriate age at vaccine administration (latency: same day). At the time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- ADACEL; ACTHIB; DAPTACEL; ROTAVIRUS VACCINE; PREVNAR
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 8,0
- Geschlecht
- F
- Eingang
- 22.11.2021
- Impfdatum
- 18.11.2021
- Beginn
- 18.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
no adverse effects, pt gwas given Dtap but it should have been Tdap as pt is older than 6 years old. She was behind on her vaccines and had not received her 5th dose of dtap prior to this date
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- no
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- no
- Allergien
- no
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 08.10.2021
- Impfdatum
- 08.10.2021
- Beginn
- 08.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Wrong product administered
Symptomtext
ACCIDENTALLY GAVE TDAP INSTEAD OF DTAP. NO ADVERSE REACTION.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 02.09.2021
- Impfdatum
- 02.09.2021
- Beginn
- 02.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
Client received both one dose of Pediarix and one dose of IPV in the same visit.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 13.08.2021
- Impfdatum
- 12.08.2021
- Beginn
- 12.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Wrong product administered
Symptomtext
PATIENT ACCIDENTLY GIVEN PENTACEL INSTEAD OF ACTHIB - THEREFORE PATIENT RECEIVED AN EXTRA DTAP AND AN EXTRA IPV THAT DAY. PARENT NOTIFIED VIA SPANISH TRANSLATION.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -